Advanced Biomed Inc
ADVB0.364USD
+0.020+5.81%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
7.88MMarket Cap
LossP/E TTM
More Details of Advanced Biomed Inc Company
Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The Company is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. It has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The Company offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.
Advanced Biomed Inc Info
Ticker SymbolADVB
Company nameAdvanced Biomed Inc
IPO dateMar 06, 2025
CEO- -
Number of employees31
Security typeOrdinary Share
Fiscal year-endMar 06
Address401 Ryland St
CityRENO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code89502
Phone1862120510823
Websitehttp://www.advanbiomed.com/
Ticker SymbolADVB
IPO dateMar 06, 2025
CEO- -
Company Executives of Advanced Biomed Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Alan
Mr. Alan
Director of Investor Relations
Director of Investor Relations
--
--
Dr. I-Fang (Steven) Cheng, Ph.D.
Dr. I-Fang (Steven) Cheng, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Alan
Mr. Alan
Director of Investor Relations
Director of Investor Relations
--
--
Dr. I-Fang (Steven) Cheng, Ph.D.
Dr. I-Fang (Steven) Cheng, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Dec 4
Updated: Thu, Dec 4
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Lu (Yi Ph.D.)
31.00%
Pau (Hung To)
16.29%
Advance on Ventures Ltd
10.09%
Jin (Yimin)
8.11%
Luo (Xiaoyuan)
6.46%
Other
28.05%
Shareholders
Shareholders
Proportion
Lu (Yi Ph.D.)
31.00%
Pau (Hung To)
16.29%
Advance on Ventures Ltd
10.09%
Jin (Yimin)
8.11%
Luo (Xiaoyuan)
6.46%
Other
28.05%
Shareholder Types
Shareholders
Proportion
Individual Investor
67.44%
Corporation
10.09%
Hedge Fund
0.64%
Venture Capital
0.24%
Investment Advisor
0.18%
Research Firm
0.15%
Other
21.25%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
6
262.83K
0.61%
--
2025Q3
6
262.83K
0.61%
+131.46K
2025Q2
4
131.38K
0.05%
+120.16K
2025Q1
1
11.21K
0.00%
+11.21K
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Lu (Yi Ph.D.)
6.71M
31%
--
--
Jul 23, 2025
Pau (Hung To)
3.52M
16.29%
--
--
Jul 23, 2025
Advance on Ventures Ltd
2.18M
10.09%
--
--
Jul 23, 2025
Jin (Yimin)
1.75M
8.11%
--
--
Jul 23, 2025
Luo (Xiaoyuan)
1.40M
6.46%
-250.00K
-15.17%
Jul 23, 2025
Shen (Nanzhen)
1.21M
5.59%
--
--
Jul 23, 2025
Citadel Advisors LLC
57.67K
0.27%
+46.45K
+414.30%
Jun 30, 2025
Virtu Americas LLC
24.28K
0.11%
+24.28K
--
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Advanced Biomed Inc?
The top five shareholders of Advanced Biomed Inc are:
Lu (Yi Ph.D.) holds 6.71M shares, accounting for 31.00% of the total shares.
Pau (Hung To) holds 3.52M shares, accounting for 16.29% of the total shares.
Advance on Ventures Ltd holds 2.18M shares, accounting for 10.09% of the total shares.
Jin (Yimin) holds 1.75M shares, accounting for 8.11% of the total shares.
Luo (Xiaoyuan) holds 1.40M shares, accounting for 6.46% of the total shares.
Lu (Yi Ph.D.) holds 6.71M shares, accounting for 31.00% of the total shares.
Pau (Hung To) holds 3.52M shares, accounting for 16.29% of the total shares.
Advance on Ventures Ltd holds 2.18M shares, accounting for 10.09% of the total shares.
Jin (Yimin) holds 1.75M shares, accounting for 8.11% of the total shares.
Luo (Xiaoyuan) holds 1.40M shares, accounting for 6.46% of the total shares.
What are the top three shareholder types of Advanced Biomed Inc?
The top three shareholder types of Advanced Biomed Inc are:
Lu (Yi Ph.D.)
Pau (Hung To)
Advance on Ventures Ltd
Lu (Yi Ph.D.)
Pau (Hung To)
Advance on Ventures Ltd
How many institutions hold shares of Advanced Biomed Inc (ADVB)?
As of 2025Q4, 6 institutions hold shares of Advanced Biomed Inc, with a combined market value of approximately 262.83K, accounting for 0.61% of the total shares. Compared to 2025Q3, institutional shareholding has increased by --.
What is the biggest source of revenue for Advanced Biomed Inc?
In --, the -- business generated the highest revenue for Advanced Biomed Inc, amounting to -- and accounting for --% of total revenue.
